Banque Delubac & Cie accompanied and advised Bonyf NV, a specialist in oral care, for its listing on Euronext Access Paris.
Bonyf NV (Euronext Access Paris: MLBON) is a Belgian company specialising in the research, development, production and distribution of oral products. Its range consists of 15 products in the field of dental, oral, orthodontic and wound care. They are produced in the Bonyf factory in Switzerland in accordance with strict international regulations to ensure consistent product quality.
Innovation is at the heart of bonyf's offer through a wide range of patented products (7 active patents and 3 additional patents pending), spanning 20 years of in-house research and development carried out in bonyf Liechtenstein. bonyf products are marketed in 36 countries by pharmaceutical companies, pharmacy and parapharmacy chains and dental product retailers.
The transaction was completed following the admission to trading, on 17 March 2022, of 588,600 shares making up the company's share capital, at a price of 12 euros per share.
This transaction will allow bonyf NV to develop its notoriety and increase the visibility of its brands/products.
Jean-Pierre Bogaert, CEO and founder states: “The listing of bonyf NV shares on Euronext Access® Paris is an important step in the development of the company. Our listing will strengthen our notoriety and facilitate our access to new clients, especially internationally. They will appreciate that bonyf adopts the best practices in the sector and offers quality corporate and financial information. Our presence in a market adapted to the size of our company will give us the flexibility necessary to pursue and accelerate our growth projects. After more than 20 years of R&D innovation and quality certification, bonyf is now at a major strategic turning point in its history. We are confident that we will be able to reap the benefits of our investments in the coming years and thanks to the stock market, we are expanding our future fundraising opportunities.”
Banque Delubac & Cie acted as advisor for this transaction.
Founded in 1979, bonyf specialises in the development, production and marketing of oral care products. Bonyf's innovation strategy enables it to improve the quality of life of people suffering from oral diseases. The company has an R&D centre in Liechtenstein in the “Dental Valley”, a production plant in Switzerland and distributes its product lines in 36 countries throughout the world. Benefiting from 7 patents protecting formulations and products developed in-house, the company anticipates a strong development of its activity in the coming months driven by an oral-dental care market in sustained growth.
About Banque Delubac & Cie
Created in 1924, Banque Delubac & Cie is an independent financial institution offering specialised banking and financial services. With 280 employees, it is present on several regional sites across France.
Its Corporate & Investment Bank department has been developing for 10 years advisory services for mergers and acquisitions, engineering and financial operations for listed and unlisted companies.